Orphan drug “Naltrexone” initially formulated to help reverse narcotic overdose was later found to help a wide variety of auto-immune disorders when used at much lower dose. Now referred to as “Low dose naltrexone” or “LDN” this therapy is offering new hope to many suffering from a variety of disorders. Dr. Rachel Krajewski, RPh is a compounding pharmacist and will discuss what LDN is and how it might help.